Stem cell centers on the rise, claim high efficacy for treatment of knee osteoarthritis

March 6, 2018, American Academy of Orthopaedic Surgeons

Even with a lack of peer-reviewed evidence, the number of centers advertising stem cell therapies for osteoarthritis (OA) of the knee are increasing in the United States. These centers claim an 80 percent success rate, according to research presented this week at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). Of the 65 centers that provided pricing information to treat OA of the knee, the cost ranged from $1,150 to $12,000, with an average of $5,000 per injection.

"Our role as is to provide accurate, credible information on options to our patients," said George Muschler, MD, Professor of Orthopaedic Surgery and Director at the Regenerative Medicine Laboratory at Cleveland Clinic. "Recent systematic reviews of cellular therapies for the treatment of knee OA (over 400 papers screened) have found poor levels of evidence for the efficacy of these treatments to date. Current evidence does not justify the rapid rate of growth for these therapies."

Osteoarthritis affects more than 27 million Americans and an estimated 9.9 million adults suffer from OA the knee. Risk factors include age, genetics, being overweight, and repetitive knee bending or heavy lifting.ii Women have an increased risk of osteoarthritis of the knee as they age.ii OA of the knee causes joint pain, stiffness and makes movement difficult.ii

Study details

The researchers contacted 317 U.S. centers that offer direct-to-consumer stem cell musculoskeletal treatments. All communications were via phone or email. The 273 that were successfully contacted were asked for information on same-day stem cell injections for OA of the knee, including clinical efficacy and cost.

Sixty-five centers provided pricing for a same-day stem cell unilateral injection. The mean cost for each therapy was $5,156, with prices varying from $1,150 to $12,000. Fourteen centers charged less than $3,000 and 10 clinics charged more than $8,000 per injection. As insurance doesn't cover stem cell treatments, coverage is paid 100 percent by the patient.

Regarding treatment effectiveness, 36 centers provided data with the mean marketed clinical efficacy of 82.2 percent. Ten clinics claimed 90-100 percent efficacy, 15 claimed 80 to 90 percent efficacy, 10 claimed 70 to 80 percent efficacy and one claimed 55 percent of greater clinical efficacy. The researchers found no correlation between treatment costs and marketed clinical efficacy.

"The claim of "stem cell" carries a high level of expectations for the potential benefits, but research is still many years away from providing clear evidence of effective treatment to patients," said Nicolas S. Piuzzi, MD, lead author and Clinical Scholar in Orthopaedic Regenerative Medicine and Cellular Therapy in the Department of Orthopaedic Surgery at Cleveland Clinic. "As clinicians and researchers, we have ethical, scientific, legal and regulatory concerns. Patients need to be aware of the status of research within the field. If they receive information from anyone offering a treatment claim of an 80 to 100 percent successful recovery, they should be concerned in observance of published peer-reviewed evidence."

Explore further: One-third of costs prior to knee replacement for non-recommended therapies

Related Stories

One-third of costs prior to knee replacement for non-recommended therapies

March 14, 2017
In the year prior to total knee replacement (TKR) surgery, almost one-third of the costs for treatment of arthritis symptoms went toward strategies not recommended by the American Academy of Orthopaedic Surgeons (AAOS), according ...

Weighing nonsurgical treatment options for knee osteoarthritis pain

September 19, 2017
Osteoarthritis (OA) is a progressive "wear and tear" disease of the joint. Osteoarthritis of the knee (knee OA) may not be totally preventable but according to Elizabeth Matzkin, MD, an orthopaedic surgeon specializing in ...

X-rays: The first and best screening tool in diagnosing knee pain among middle-aged patients

September 9, 2016
Knee pain is common among Americans age 40 and up. Nearly 1 in 17 people visit doctors' offices each year for knee pain or injuries from osteoarthritis—a progressive "wear and tear" disease of the joints. Those odds increase ...

AAOS releases guidelines for surgical treatment of osteoarthritis of the knee

December 10, 2015
The American Academy of Orthopaedic Surgeons (AAOS) today introduced a new clinical practice guideline (CPG) for adults undergoing surgery to improve motion and relieve pain caused by osteoarthritis of the knee. The guidelines ...

AAOS Board approves treatment criteria for carpal tunnel syndrome and knee osteoarthritis

December 12, 2016
The American Academy of Orthopaedic Surgeons (AAOS) Board of Directors has approved new Appropriate Use Criteria (AUC) for the management of carpal tunnel syndrome (CTS) and the surgical management of osteoarthritis of the ...

Autologous adipose-derived stromal cells may ease knee OA

June 27, 2016
(HealthDay)—For patients with knee osteoarthritis, a single intra-articular injection of autologous adipose-derived stromal cells (ASCs) can reduce pain and inflammation, according to research published online May 23 in ...

Recommended for you

Researchers watch the knee degenerate and understand how osteoarthritis may begin

December 12, 2018
For hockey great Bobby Orr, a torn knee ligament ended his career at age 30. Orr had more than 17 knee operations, at one point having his meniscus removed—the cartilaginous tissue that helps stabilize and lubricate the ...

3-D printing offers helping hand to people with arthritis

December 11, 2018
Adaptive aids are expensive. Additive manufacturing, using low-cost 3-D printers, can save upwards of 94 percent for simple household items.

Potential arthritis treatment prevents cartilage breakdown

November 28, 2018
Osteoarthritis, a disease that causes severe joint pain, affects more than 20 million people in the United States. Some drug treatments can help alleviate the pain, but there are no treatments that can reverse or slow the ...

Surgical adhesions can be treated, prevented in mice

November 28, 2018
A cellular culprit—as well as a possible treatment—for a common, sometimes life-threating post-surgical complication has been identified by researchers at the Stanford University School of Medicine.

Cost and weight-loss potential matter most to bariatric surgery patients

November 28, 2018
A JAMA Surgery study found that patients are likely to base their weight loss surgery choice on expected out-of-pocket costs, and how much weight they can lose—not risk of complications or recovery time.

Treating spinal pain with replacement discs made of 'engineered living tissue' moves closer to reality

November 21, 2018
For the first time, bioengineered spinal discs were successfully implanted and provided long-term function in the largest animal model ever evaluated for tissue-engineered disc replacement. A new Penn Medicine study published ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

WebSkipper
not rated yet Mar 06, 2018
Believe it. It's true.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.